Purpose: The purpose of this study was to review the complications of transaxillary arteriography (TRAX), determine clinical factors associated with their occurrence, and define optimal treatment methods. Methods: A retrospective review of 842 consecutive TRAX studies performed in a large, urban, tertiary care, academic medical center was undertaken. Patients with complications were compared with a concurrent randomized control group without complications with the use of a multivariate analysis model. Results of operative therapy for nerve injury were compared with those of nonoperative therapy. Results: Nineteen (2.3%) complications were identified including 14 nerve injuries, four expanding hematomas/pseudoaneurysms without neurologic deficit, and one puncture site thrombosis. Several statistically significant or suggestive findings associated with the occurrence of complications were identified: female sex (odds ratio [OR] = 4.7), systolic blood pressure _>150 mm Hg at the conclusion of TRAX (OR = 9.5), periprocedural systemic heparin anticoagulation (OR = 7.9), concomitant use of intraarterial thrombolysis or percutaneous angioplasty (OR = 12.0), and duration of procedure >90 minutes (OR = 4.0). Patients who underwent prompt exploration (<4 hours from symptom onset) for nerve injuries were more likely to have complete resolution of their neurologic deficits (five of six patients) than those who were observed or underwent delayed operation (three of eight patients) (OR = 8.3). Conclusions: Aggressive treatment of post-TRAX hypertension, limitation of TRAX duration, delay of postprocedure anticoagulation, and use of alternative sites for arterial puncture in female patients or patients undergoing catheter-based intervention may reduce the incidence of TRAX-related complications. In patients who have neurologic deficits prompt surgical exploration of the ptmcture site with decompression of the involved nerve(s) may reduce the incidence of prolonged deficits. (J Vasc Surg 1996;23:844-50.) Transaxillary arterial catheterization is a well established, practical, and safe approach for diagnostic and therapeutic procedures when transfemoral access is not possible or undesirable. Nevertheless complications such as hematoma formation with nerve injury, arterial thrombosis, distal embolism, pseudoaneurysm formation, and arteriovenous fistula have been
described. >1° Mthough several reports have characterized the nature and incidence of these complications, none has evaluated factors associated with their occurrence.
Nerve injury caused by compression from local bleeding is the most common and potentially debilitating complication after transaxillary arteriography (TRAX). Because of the close proximity of the distal axillary and proximal brachial arteries to the brachial plexus, even a small puncture site hematoma can produce significant nerve compression and dysfunction. In addition, optimal management of these injuries is unclear, with some authorities advocating prompt exploration for any neurologic deficit 1-4 and others reserving operative decompression for motor deficits only. s '6 This study was undertaken in part to clarify this debate.
MATERIAL AND METHODS
Patients with complications after undergoing TRAX were identified through the database of the Henry Ford Hospital Vascular Surgery Registry and the records of the Special Procedures Division of the Department of Diagnostic Radiology over a 9-year period from January 1, 1986, through December 31, 1994. Data collected for each patient included the nature of the complication, demographic profile, factors related to the performance of TRAX, treatment selected for the complication, and the outcome of the complication. The specific demographic, periprocedural, and procedure-related factors included age, sex, race, height, weight, body mass index (wt(kg)/ht(m)2), antithrombotic therapy, antihypertensive therapy, side of puncture, blood pressure at the beginning and end of the procedure, diagnostic study performed, indication for the study, interventional procedure performed, if any, duration of the procedure, number of catheters used, and size of the largest catheter used.
All patients undergoing TRAX were tested for routine coagulation parameters before the procedure. In all patients considered in the study (cases + control group), the prothrombin time was less than 15 seconds (normal 11 to 14 seconds), the activated partial thromboplastin time was within the normal range, and the platelet count was more than 80,000. Patients receiving systemic heparin anticoagulation were taken offheparin infusion at least 4 hours before undergoing TRAX.
Nerve injuries after TRAX were diagnosed by the presence of sensory deficits, motor deficits, or both within the distribution of the median, ulnar, or radial nerves. Recovery from nerve injury was considered complete when all sensory and motor deficits had resolved at last follow-up or incomplete when sensory or motor deficits remained at last follow-up. The time from symptom onset to resolution was recorded for those patients with complete recovery. Symptom resolution was evaluated with respect to treatment with an odds ratio (OR) with 95 % confidence interval (CI) and Fisher's exact test.
The selected management of TRAX complications was at the discretion of the attending vascular surgeon. Management options were divided into observation, prompt exploration (operation performed _<4 hours from onset of symptoms), or delayed exploration (operation performed >4 hours from onset of symptoms). The time from the onset of neurologic symptoms to operation was recorded for each patient. Operative intervention for nerve injury and more obvious bleeding complications (pseudoaneurysm or expanding hematoma) consisted of exposure of the arterial puncture site, careful hematoma evacuation, and arterial repair.
For each patient in whom a TRAX complication occurred, four patients undergoing TRAX without complication were randomized as a control group for comparison of the study parameters. One patient in the control group was eventually excluded, because his puncture site was the distal brachial rather than the proximal brachial artery. Comparisons between patients with TRAX complications and patients in the control group were made with OR with 95% CI and g 2 analysis for conditional variables and ORwith 95% CI and t test for continuous variables. Multivariate logistic regression analysis was then performed to test the independence of associations found by univariate analysis. Results are expressed as adjusted OR with 95% C1 and as adjusted g 2 values. No significant differences between study cases and the control group were found when the indication for procedure, angiographer, or calendar year in which the study was performed were considered.
RESULTS
During the 9-year study period 842 transaxillary procedures were performed in 674 patients. Five hundred forty-nine patients had one transaxillary procedure performed during the study period. One hundred twenty-five patients underwent more than one study. This group included two TRAX (95), three TRAX (21), four TRAX (six), five TRAX (two), and six TRAX in a single patient. Nineteen (2.3%) complications were identified in the 842 consecutive procedures and consisted of 14 (1.7%) nerve injuries, four (0.5%) bleeding complications without nerve injury (pseudoaneurysm or expanding hematoma), and one (0.1%) puncture site arterial thrombosis. The median nerve was affected in 9 (64%) of the 14 patients, the ulnar nerve in 6 (43%), and the radial nerve in 1 (7%). Sensory deficits alone were noted in 9 (64%) of 14 patients, whereas both sensory and motor deficits occurred in 5 (36%) ( Table I) .
A puncture site hematoma was externally identified in 10 (71%) of the 14 patients with nerve injuries. Eight of the 10 patients with identifiable hematomas and two of four patients without identifiable hematomas underwent surgical exploration, whereas the remaining four patients were observed. Operation was performed from 1.5 to 78 hours after the onset of neurologic symptoms (median, 3.5 hours). Nine of the 10 patients undergoing exploration for nerve injury had an uncomplicated operative procedure. The remaining patient had a radial nerve sensory and 7 (50) 1 (7) 1 (7) 5 (36) 14 motor deficit after undergoing exploration for a median nerve sensory deficit. Six of the 10 patients with nerve injuries undergoing puncture site exploration and two of the four treated without operation had complete resolution of their neurologic deficits. One of the two patients without identifiable hematoma who were observed rccovered completely from the nerve injury. Five of the six patients who had complete return of nerve function after undergoing exploration had no symptoms within 4 days of operation, whereas one individual had return of nerve function at 14 days after operation. One of two patients with complete return of nerve function after observation had no symptoms within 4 days after undergoing TRAX, whereas the other did not have resolution of neurologic deficits until 13 months after undergoing TRAX. The mean follow-up for patients with incomplete recovery of nerve function was 16.5 months. Nerve injuries and outcomes for the 14 affected patients are detailed in Table II .
Urgent operations (<4 hours from onset of neurologic symptoms) were performed on six patients with nerve injury. Five (83.3%) of these patients had complete resolution of their neurologic deficits. Three (37.5%) of the eight patients treated with observation or delayed exploration (>4 hours after symptom onset) had complete nerve function recovery. Patients who underwent urgent puncture site exploration with hematoma evacuation and arterial repair were 8.3 times more likely to recover completely from their nerve injury than patients observed or treated with delayed exploration (95% CI 0.5 to 471.1) (p = 0.14).
Puncture site exploration was recommended to three of the four patients with pseudoaneurysms or expanding hematomas. The single patient treated without operation had a small puncture site pseudoaneurysm without associated neurologic deficit. The pseudoaneurysm resolved without further therapy as documented by duplex scanning 1 month later. The patient with arterial thrombosis was not offered immediate operation because of the absence of ischemic symptoms. Within 1 week after TRAX was performed, this patient had regaincd normal pulses, suggesting recanalization of the occluded segment or collateral compensation.
Whereas a number of factors had a statistically significant association with the occurrence of TRAX complications by univariate analysis, in the multivariate logistic regression analysis model three factors remained significant (Table III) . Female patients were 4.7 times more likely to have a complication of TRAX than male patients (95% CI 1.0 to 21.8) (p < 0.05). Patients with a systolic blood pressure ___150 mm Hg at the conclusion of TRAX were 9.5 times more likely to have a complication than were those with a systolic blood pressure less than 150 mm Hg (95% CI 1.2 to 75.5) (p < 0.04). When systemic heparin anticoagulation was used in the periprocedural period, patients were 7.9 times more likely to have a complication (95% CI 1.3 to 47.0) (p < 0.03).
DISCUSSION
Although the term "transaxillary arteriography" is used by convention, the actual puncture site for the procedures considered in this report was the proximal brachial artery (Fig. 1) . Because of the proximity of the brachial plexus to the distal axillary/proximal brachial artery, the potential for nerve injury with arterial puncture at this site is obvious. Injury to the nerves of the upper extremity as a result of TRAX occurred in 1.7% of patients in this study. Previous reports have recorded incidences ranging from 0.6% to 2.8%. x,5,7,8 This report may underestimate the true incidence of nerve injury, however, because of potential problems in identification of deficits in patients undergoing outpatient procedures and possible lack of appreciation of symptoms by care providers.
The relative frequency of dysfunction of the brachial nerves after TRAX probably results from their anatomic relationship to the distal axillary/proximal brachial artery (Figs. 1 and 2) . The median nerve has previously been reported to be at greatest risk with TRAX, 9 and this finding is confirmed by this report. The ulnar nerve was less frequently involved, and only one injury of the radial nerve was encountered.
Nerve injuries after TRAX have been recognized in the absence of an externally identifiable hematoma, s The fascial sheath surrounding the neurovascular structures of the upper arm can prevent egress of blood into the subcutaneous tissues. Although historically this fascial sheath has been identified as the axillary sheath, recent anatomic studies have focused attention on the medial brachial fascia, s This inelastic investing fascia of the arm forms a compartment, the medial brachial fascial compartment, around the neurovascular structures of the upper arm with its extensions of fascia between muscle groups attaching to the humerus (Fig. 2) . A relatively small hematoma within the medial brachial fascial compartment resulting from an arterial puncture may be enough to compress adjacent nerves yet be difficult to detect on physical examination. This description is consistent with operative findings of small subfascial hematomas in both patients who underwent exploration for nerve deficits without evidence of an externally detectable puncture site hematoma. Local anesthetic used before artcrial puncture may cause brachial plexus neurologic symptoms that are difficult to differentiate from symptoms resulting from nerve compression. In this study only 2 of the 14 patients with nerve injuries had immediate nerve deficit after undergoing TRAX. When brachial nerve symptoms begin immediately after TRAX, it is advisable to observe the patient for 2 to 3 hours to allow any local anesthetic effect to resolve before contemplating exploration for a presumed nerve injury.
Hypertension, 7 anticoagulation, 7'9 and performance ofpercutaneous transluminal angioplasty 8 via the transaxillary route have all been anecdotally associated with the development of complications. Although the association of an elevated blood pressure at TRAX conclusion or the use of periprocedural anticoagulation with puncture site bleeding seems intuitively obvious, the basis for the independent association of complications with female sex is difficult to understand. If a size difference in patients explained the correlation, factoring body mass index into the multivariate model would be expected to negate the association. At present no obvious explanation accounts for the association between female sex and TRAX complications.
The use of multiple catheters, performance of percutaneous transluminal angioplasty or intraarterial thrombolytic therapy during TRAX, and duration of TRAX for 90 minutes or greater were statistically associated with TRAX complications by univariate analysis. Independent statistical significance was lost when these closely related factors were considered together in the multivariate analysis model, although long procedure duration and transaxillary catheterdirected intraarterial thrombolytic therapy, or percutaneous transluminal angioplasty continued to have a suggestive association with complications. The logical explanation for this possible association is an increase in the potential for bleeding into the medial brachial fascial compartment related to the longer residence rime of a catheter through the arterial wall, the use of larger diameter catheters, and the use of antithromboric agents.
A selective approach to puncture site exploration for nerve deficits after TRAX has been suggested by some authorities. With this approach operation is undertaken only when motor deficits S,6 or "severe" sensory or motor deficits are present. 8 Four patients in this series were observed with sensory deficits (two refused operation); two had complete resolution of their deficits, one early (<4 days) and one late (13 months), and two had continued deficits 2 and 9 months later. Five individuals underwent operation for sensory deficits alone. Three who underwent exploration within 4 hours of the onset of symptoms had complete deficit resolution of their deficits within 4 days, whereas two had only partial recovery after undergoing delayed exploration. These results suggest that even patients with sensory deficits alone may benefit from operative decompression.
Prompt operation after development of an upper extremity neurologic deficit may result in immediate resolution of symptoms or hasten recovery of function. ~° Individuals who underwent prompt exploration in this series were 8.3 times more likely to have complete recovery than patients who were either observed or underwent delayed operation, although the difference did not reach statistical significance. In addition, recovery ofneurologic function after timely exploration was rapid in most cases. As a result of these observations prompt exploration for any sensory or motor nerve deficit after TRAX is suggested, because it appears to result in more complete and rapid recovery of nerve function. take these patients with brachial plexus symptoms to the operating room even despite lack of physical findings. The artery angiogram site should be explored and decompressed, if necessary.
I do have several questions. Number one, I would like to ask, did the neurologic deficit correlate with the amount of hematoma? For example, if one has just a small hematoma, is that more likely to have a sensory deficit versus a deficit that involves both sensory and motor nerves? What was the cause of injury in these 4 of 14 patients who had negative explorations? Could it be that indeed the needle itself somehow injured a nerve? Do you think it is some chemical irritation?
Dr. Richard Chit-wood. The first question was, did the hematoma size correlate with the amount of deficit? We actually did not find that that was the case. In fact, we made no attempt to follow hematomas per se that did not develop a neurologic deficit or in which pseudoaneurysm was not a concern. There were many large hematomas that had no neurologic deficit, and certainly at exploration the seriousness of nerve deficit did not seem to correlate with the amount ofhematoma. At exploration in all 10 patients who underwent surgery for neurologic deficit, all of those patients did indeed have hematoma surrounding the axillary artery. There were no patients who did not have any evidence of hematoma. There were patients who did not have evidence ofhematoma on external examination of the puncture site.
As regards the recommendation to explore urgently, I think the evidence suggests that may be the case. One group of patients we do not suggest operating on immediately is the group of patients who have their neurologic symptoms immediately at the conclusion of the procedure. Those patients sometimes have the effect of local anesthesia administered at the time of their procedure, causing nerve deficits. We advocate actually that those patients be observed for 2 to 3 hours, and if their neurologic deficits do not resolve within that time, that they undergo exploration.
Dr. William D. Turnipseed (Madison, Wis.). Dr. Chitwood, you focused on physical findings such as the presence of a hematoma or neurologic defects as your red flags for some kind of interventional treatment. What you have not discussed is the prevalence of pain syndromes associated with transaxillary arteriography. Is this a common problem? Regarding surgical timing, is there a window beyond which you would not explore these patients, even if you are convinced that the injury is, as you have already described, the cause for the problem?
Dr. Chitwood. With regards to pain syndrome, we did have one patient who eventually had reflex sympathetic dystrophy and bad pain syndrome in the upper extremity. However, most of the symptomatology has been purely on a neurologic basis in terms of motor deficit or sensory deficit, which is what this was based on.
As regards the timing of operation, we have explored patients up to as late as 78 hours after the initial injury. That particular patient did not notify anybody that she was having symptoms after the arteriogram, and when they were recognized, she was explored promptly. However, the symptoms were there a long time. We have not set a limit, and I just do not know the answer to whether there is any benefit of exploration late.
